Neuroradiology
Case TypeClinical Case
Authors
Deepthi Sethumadhavan, Prabakaran M. S., Geetha Soliappan
Patient9 years, female
A 9-year-old girl reported to us for epilepsy imaging. The birth history was uneventful. History of developmental delays such as delay in unsupported walking, speech delay and febrile seizures were there. Over the years, the child developed slowly progressive neurological dysfunction and cerebellar ataxia with slow intellectual decline.
Brain magnetic resonance imaging (MRI) showed:
Background
Cerebral organic acidurias (COA) are rare neurometabolic diseases characterised predominantly by central nervous dysfunction. L-2-hydroxyglutaric aciduria is a rare, infantile-onset, autosomal recessive organic aciduria caused by L-2-hydroxyglutarate dehydrogenase enzyme deficiency, which is involved in the oxidation of L-2-hydroxyglutarate (L-2-HG) to alpha 2-ketoglutarate. Increased L-2-HG in tissues induces free radical formation and increases glutamate uptake in synaptosomes and synaptic vesicles. It is toxic to the brain, causes leukoencephalopathy, and is also an oncometabolite [1].
Clinical Perspective
L-2-HGA patients present with cerebellar ataxia, extrapyramidal and pyramidal symptoms and slowly progressive neurodegeneration with seizures and macrocephaly [2].
Imaging Perspective
Brain MRI shows a symmetric T2 and FLAIR high signal intensity and T1 low signal intensity of the subcortical white matter (U-fibres), globus pallidus, and dentate nucleus. White matter involvement presents a centripetal pattern, starting in the U-fibres and extending to the deeper white matter with a confluent pattern as the disease progresses [3].
Even in advanced cases, the corpus callosum, internal capsule, and periventricular white matter are spared. There is no involvement of the brainstem and cerebellar white matter. There is no contrast enhancement and no restricted diffusion. Advanced cases show cerebral and cerebellar vermis atrophy [3].
The definite diagnosis is made by urinary organic acid screening with gas chromatography-mass spectrometry and liquid chromatography, i.e., tandem mass spectrometry [3].
Outcome
There have been reports of significant clinical response with riboflavin; an early diagnosis thus extends an opportunity to modify the clinical course [4].
Take Home Message / Teaching Points
Written informed patient consent for publication has been obtained.
[1] Bozaci AE, Er E, Ünal AT, Taş İ, Ayaz E, Ozbek MN, Durmaz A, Aykut A, Kose M (2023) Glutaric aciduria and L-2-hydroxyglutaric aciduria: Clinical and molecular findings of 35 patients from Turkey. Mol Genet Metab Rep 36:100979. doi: 10.1016/j.ymgmr.2023.100979. (PMID: 37275239)
[2] Ahmed S, Siddiqui A, DeBerardinis RJ, Ni M, Gu Lai W, Cai F, Vu HS, Afroze B (2023) L-2-hydroxyglutaric aciduria - review of literature and case series. Ann Med Surg (Lond) 85(4):712-7. doi: 10.1097/MS9.0000000000000326. (PMID: 37113859)
[3] American Journal of Neuroradiology. L-2-hydroxyglutaric aciduria. [Online]. https://www.ajnr.org/ajnr-case-collections-diagnosis/l-2-hydroxyglutaric-aciduria
[4] Muthusamy K, Sudhakar SV, Christudass CS, Chandran M, Thomas M, Gibikote S (2019) Clinicoradiological Spectrum of L-2-Hydroxy Glutaric Aciduria: Typical and Atypical Findings in an Indian Cohort. J Clin Imaging Sci 9:3. doi: 10.25259/JCIS-9-3. (PMID: 31448154)
URL: | https://eurorad.org/case/18519 |
DOI: | 10.35100/eurorad/case.18519 |
ISSN: | 1563-4086 |
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.